Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2020

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions

CardiomyopathyHeart FailureHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Interventions

OTHER

Best Practice

Given standard of care

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Mesenchymal Stem Cell Transplantation

Given IV

DRUG

Mesenchymal Stem Cell Transplantation

Given transendocardially

Trial Locations (1)

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER